Published in Am J Cardiol on May 25, 2007
RAS blockade with ARB and ACE inhibitors: current perspective on rationale and patient selection. Clin Res Cardiol (2008) 1.34
High-salt diet and hypertension: focus on the renin-angiotensin system. Kidney Blood Press Res (2010) 1.04
Angiotensin-(1-7) prevents diabetes-induced attenuation in PPAR-gamma and catalase activities. Eur J Pharmacol (2010) 1.00
Comparative assessment of angiotensin receptor blockers in different clinical settings. Vasc Health Risk Manag (2009) 0.94
Blocking the RAAS at different levels: an update on the use of the direct renin inhibitors alone and in combination. Vasc Health Risk Manag (2010) 0.87
Cardiovascular protection for all individuals at high risk: evidence-based best practice. Clin Res Cardiol (2008) 0.86
PPARs in the Renal Regulation of Systemic Blood Pressure. PPAR Res (2010) 0.82
Prevention and intervention studies with telmisartan, ramipril and their combination in different rat stroke models. PLoS One (2011) 0.79
RAAS inhibition and mortality in hypertension. Glob Cardiol Sci Pract (2013) 0.78
Effects of aqueous leaf extract of Asystasia gangetica on the blood pressure and heart rate in male spontaneously hypertensive Wistar rats. BMC Complement Altern Med (2013) 0.77
Long-term antihypertensive effects of far-infrared ray irradiated from wooden board in spontaneously hypertensive rats. BMC Complement Altern Med (2016) 0.75
HYDRA: possible determinants of unsatisfactory hypertension control in German primary care patients. Blood Press (2004) 0.83
Effect of high-dose valsartan on inflammatory and lipid parameters in patients with Type 2 diabetes and hypertension. Diabetes Res Clin Pract (2010) 0.76